CUE vs DE · rev $9.3M vs P/E 25, rev $45.68B
Cue Biopharma (CUE) versus Deere & Company (DE) — a side-by-side from cached financials, not a winner call.
Cue Biopharma (CUE) is a biotechnology company listed on US.
Deere & Company (DE) is a farm & heavy construction machinery company listed on US. It is led by John May.
Latest reported CUE revenue for 2024-12-31 was $9.3M. Net income was -$40.7M. Revenue was up 69.2% from 2023-12-31 to 2024-12-31. CUE currently screens at market cap $59.5M.
Latest reported DE revenue for 2025-11-02 was $45.68B. Net income was $5.03B. Revenue was down 11.7% from 2024-10-27 to 2025-11-02. DE currently screens at market cap $137.72B and trailing P/E 24.6.
CUE currently screens at market cap $59.5M. DE currently screens at market cap $137.72B and trailing P/E 24.6.
Not investment advice. Open the CUE and DE stock pages for the full models.
Not investment advice.